Eugene A. Woods

CIK: 0001762647

Transaction Breakdown

Open Market Buys (P)1 (8.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)11 (91.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

JNJ

JOHNSON & JOHNSON

Director

Discretionary Trading P&L

Holdings

Transaction History (12 total)

JNJ
JOHNSON & JOHNSON
Sep 8, 2026
Award(A)
Deferred Share Units
Direct
136 shares at avg. $276.31-
JNJ
JOHNSON & JOHNSON
Jun 9, 2026
Award(A)
Deferred Share Units
Direct
161 shares at avg. $232.79-
JNJ
JOHNSON & JOHNSON
Apr 23, 2026
Award(A)
Deferred Share Units
Direct
975 shares-
JNJ
JOHNSON & JOHNSON
Mar 10, 2026
Award(A)
Deferred Share Units
Direct
155 shares at avg. $242.14-
JNJ
JOHNSON & JOHNSON
Dec 9, 2025
Award(A)
Deferred Share Units
Direct
186 shares at avg. $202.12-
JNJ
JOHNSON & JOHNSON
Sep 9, 2025
Award(A)
Deferred Share Units
Direct
211 shares at avg. $178.07-
JNJ
JOHNSON & JOHNSON
Jun 10, 2025
Award(A)
Deferred Share Units
Direct
231 shares at avg. $155.23-
JNJ
JOHNSON & JOHNSON
Apr 24, 2025
Award(A)
Deferred Share Units
Direct
1.3K shares-
JNJ
JOHNSON & JOHNSON
Mar 4, 2025
Award(A)
Deferred Share Units
Direct
188 shares at avg. $166.10-
JNJ
JOHNSON & JOHNSON
Dec 10, 2024
Award(A)
Deferred Share Units
Direct
209 shares at avg. $149.67-
JNJ
JOHNSON & JOHNSON
Sep 10, 2024
Award(A)
Deferred Share Units
Direct
188 shares at avg. $165.94-
JNJ
JOHNSON & JOHNSON
Apr 30, 2024
Purchase(P)
Indirect
100 shares at avg. $145.53$15K

		Type	Shares	Price		Ownership
Sep 8, 2026	JNJ JOHNSON & JOHNSON	Award(A) Deferred Share Units	136	$276.31	-	Direct
Jun 9, 2026	JNJ JOHNSON & JOHNSON	Award(A) Deferred Share Units	161	$232.79	-	Direct
Apr 23, 2026	JNJ JOHNSON & JOHNSON	Award(A) Deferred Share Units	975	-	-	Direct
Mar 10, 2026	JNJ JOHNSON & JOHNSON	Award(A) Deferred Share Units	155	$242.14	-	Direct
Dec 9, 2025	JNJ JOHNSON & JOHNSON	Award(A) Deferred Share Units	186	$202.12	-	Direct
Sep 9, 2025	JNJ JOHNSON & JOHNSON	Award(A) Deferred Share Units	211	$178.07	-	Direct
Jun 10, 2025	JNJ JOHNSON & JOHNSON	Award(A) Deferred Share Units	231	$155.23	-	Direct
Apr 24, 2025	JNJ JOHNSON & JOHNSON	Award(A) Deferred Share Units	1,316	-	-	Direct
Mar 4, 2025	JNJ JOHNSON & JOHNSON	Award(A) Deferred Share Units	188	$166.10	-	Direct
Dec 10, 2024	JNJ JOHNSON & JOHNSON	Award(A) Deferred Share Units	209	$149.67	-	Direct
Sep 10, 2024	JNJ JOHNSON & JOHNSON	Award(A) Deferred Share Units	188	$165.94	-	Direct
Apr 30, 2024	JNJ JOHNSON & JOHNSON	Purchase(P)	100	$145.53	$14,553	Indirect

1-12 of 12 transactions

About Woods Eugene A.

Woods Eugene A. (SEC CIK 0001762647) files insider reports with the SEC as Director of JOHNSON & JOHNSON (JNJ).

Signal8 holds 12 ownership filings by Woods Eugene A. (11 Form 4, 1 Form 5), filed between Sep 12, 2024 and Sep 10, 2026. Those filings report 12 transactions, from Apr 30, 2024 to Sep 8, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Woods Eugene A.'s filings is in NEW BRUNSWICK, NJ.

Recent filings by Woods Eugene A.

Sep 8, 2026: Grant or award of JNJ derivative securities (Form 4, code A).
Jun 9, 2026: Grant or award of JNJ derivative securities (Form 4, code A).
Apr 23, 2026: Grant or award of JNJ derivative securities (Form 4, code A).
Mar 10, 2026: Grant or award of JNJ derivative securities (Form 4, code A).
Dec 9, 2025: Grant or award of JNJ derivative securities (Form 4, code A).

Other insiders filing for JOHNSON & JOHNSON (JNJ)

Pinto Daniel E, Director
HEWSON MARILLYN A, Director
Schmid Timothy, EVP, WW Chair, MedTech
Cavanaugh Thomas, EVP WW Chair, Innovative Med.
Taubert Jennifer L, EVP, WWC. Innovative Medicine
Duato Joaquin, CEO and Chairman of the Board

How to read Form 4 transaction codes